Getting antifungal drug levels right – why does it matter?

The role of the cell wall in determining host-fungus interactions

Prof. Neil Gow, University of Aberdeen

A 10 year review: Mycological Research Demystification of the ‘accidental’ pathogen Aspergillus fumigatus

Dr. Elaine Bignell, University of Manchester

Debate: “This house believes that radiology and clinical acumen are sufficient to guide IFD management, without the need for biomarkers”

Chair: Prof. Peter Donnelly
Proposers: Drs. Keith Wilson (BMT Unit, Cardiff) & Vanya Gant (Microbiology, UCLH, London)
Opposers: Drs. Brian Jones (Microbiology, Glasgow) & Stephen Ellis (Imaging, Barts, London)

Case Presentations: Cases, with interactive keypad voting, highlighting diagnostic and treatment challenges

Dr. Jonathan Lambourne, Hospital for Tropical Diseases, London
Dr. Subathira Dakshina, Genito-Urinary Medicine & HIV, Bart’s Health NHS Trust, London

A 10 year review of IFD management in Haemato-Oncology (continued) Emerging antifungal resistance in Aspergillus sp. – a clinical issue?

Prof. Paul Verweij, Microbiology, Nijmegen, The Netherlands

Molecular tools for nucleic acid and protein detection

Dr. Gemma Johnson & Prof. Stephen Bustin, Anglia Ruskin University, Chelmsford

Improved fungal assays in our lifetime? New monoclonal antibodies

Dr. Chris Thornton, University of Exeter

A 10 year review of IFD management in Haemato-Oncology Diagnostics in clinical practice: 10 years on, have we moved forward?

Prof. Rosemary Barnes, Cardiff University School of Medicine    
Dr. Mansour Ceesay, King’s College Hospital, London

Fungal Update Meeting 2015 & 2016

An annual clinical forum intended to provide updates on a wide range of fungal infection topics

http://fungalupdate.org/

Global impact of fungal disease and the challenges ahead

Prof. David Denning, Professor of Infectious Diseases in Global Health, The University of Manchester